State-owned Life Insurance Corporation of India (LIC) acquired over 1.71 crore shares in Dr Reddy’s Laboratories. Photo courtesy: Reuters
State-owned Life Insurance Corporation of India (LIC) has acquired over 1.71 crore shares in Dr Reddy’s Laboratories since June, taking its stake in the generic drug maker to more than 10%.
LIC, one of the country’s largest institutional investors, increased its stake from 8.21% in early June to 10.26% on October 15, a filing by Dr Reddy’s on Thursday showed. LIC acquired 17140819 shares through market purchase, thereby acquiring additional 2% stake.
Shares of Dr Reddy’s closed at Rs 1,240.05 on the BSE, up less than 1%. In June, LIC’s stake in Dr Reddy’s Laboratories crossed 8% after it acquired an additional 2% stake in the drugmaker with a tenure of over 2% from October 2024 onwards.
published – October 17, 2025 03:28 am IST
